|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/86 | (2006.01) |
| A61P 3/00 | (2018.01) | ||
| A61K 48/00 | (2006.01) | ||
| C12N2750/14143 | (2013.01) | ||
| A61K 38/47 | (2006.01) | ||
| C12N 15/86 | (2013.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Patento numeris | 3252161 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17168189.3 |
| Europos patento paraiškos padavimo data | 2008-06-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-11-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 924947 P | 2007-06-06 | US |
| (72) |
DODGE, James , US
CHENG, Seng , US
|
| (73) |
Genzyme Corporation ,
50 Binney Street, Cambridge, MA 02142,
US
|
| (54) | GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES |
| GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES |